The search space for protein engineering grows exponentially with complexity. A protein of just 100 amino acids has 20100 ...
The U.S. Food and Drug Administration (FDA) has granted traditional approval to Braftovi (encorafenib) for adult patients ...
MIT researchers have discovered that two common genetic mutations that cause Rett syndrome each set off a molecular chain of events that compromises the structural integrity of developing brain blood ...
BRCA1 and BRCA2 gene mutations increase the risk of hereditary breast cancer. Here's what you should know about the causes, ...
MIT researchers have discovered that two common genetic mutations that cause Rett syndrome each set off a molecular chain of events that compromises the structural integrity of developing brain blood ...
Neuroscientists discover that Rett syndrome mutations cause a leaky brain via overexpressed miRNA-126-3p, pointing to a new therapeutic target for vascular repair.
University of Queensland researchers have developed a less invasive way to test for a potential life-threatening reaction to ...
Traditional approval of encorafenib plus cetuximab and fluorouracil-based chemotherapy for patients with BRAF-mutated ...
The FDA has approved the first combination, targeted regimen for previously untreated BRAF V600E mutation-positive metastatic ...
Pasca Lab specializes in growing three-dimensional organoid models from reprogrammed stem cells, which capture molecular changes during fetal brain-like development. Because the human brain cannot be ...
The framework predicts how proteins will function with several interacting mutations and finds combinations that work well ...
Colon cancer is hitting long before the usual screening age. If you could ID who's at risk, you could screen early and save ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results